EFFECT OF THE NEW POTENT LHRH ANTAGONIST ANTIDE

被引:16
作者
HABENICHT, UF
SCHNEIDER, MR
ELETREBY, MF
机构
[1] Research Laboratories, Schering AG, Berlin
关键词
D O I
10.1016/0960-0760(90)90447-S
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ability of the new LHRH antagonist antide to induce a long-term chemical castration in adult male rats and cynomolgus monkeys was investigated. The animals were treated subcutaneously with different doses either once or on 5 consecutive days. The effects on serum concentration of LH (only rat) and testosterone and on the weights of the testes, prostates and seminal vesicles were investigated after different periods of time. Histological evaluation of testes, pituitary and hypothalamus was also performed. In the rat a clear dose-dependent inhibitory effect on the above mentioned parameters was observed whereby long-lasting castration-like effects were achieved at concentrations between 6 (less-than-or-equal-to 8 weeks) and 15 mg/kg (> 8 weeks). In the cynomolgus monkey a prolonged inhibitory effect was induced only at 15 mg/kg and the duration was only 2-3 weeks. Histologically, no signs indicative of irreversible effects were observed in either species. In conclusion: although species differences became evident in terms of the duration of a long-lasting inhibitory effect on the male reproductive system, antide exhibited such an effect in the rat and the monkey and was able to induce a chemical castration in both species. In addition, using the rat Dunning R 3327 prostatic carcinoma model, 10mg/kg antide given subcutaneously every 6 weeks for a total period of 26 weeks, had an inhibitory effect on tumor growth identical to that of castration emphasizing the suitability of this compound for treatment of prostatic cancer.
引用
收藏
页码:937 / 942
页数:6
相关论文
共 16 条
  • [1] ACUTE AND CHRONIC EFFECTS OF A GONADOTROPIN-RELEASING HORMONE ANTAGONIST ON PITUITARY AND TESTICULAR FUNCTION IN MONKEYS
    AKHTAR, FB
    WEINBAUER, GF
    NIESCHLAG, E
    [J]. JOURNAL OF ENDOCRINOLOGY, 1985, 104 (03) : 345 - 354
  • [2] CRAWFORD ED, 1988, ENDOCRINE THERAPIES, P25
  • [3] Dupont, 1984, LHRH ITS ANALOGUES, P24
  • [4] EISENBERGER M, 1988, Drugs of Today, V24, P241
  • [5] INCREASED POTENCY OF ANTAGONISTS OF THE LUTEINIZING-HORMONE-RELEASING HORMONE WHICH HAVE D-3-PAL IN POSITION-6
    FOLKERS, K
    BOWERS, C
    XIAO, SB
    TANG, PFL
    KUBOTA, M
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 137 (02) : 709 - 715
  • [6] GARNICK MB, 1986, UROLOGY, V27, P21
  • [7] GONADOTROPIN-RELEASING-HORMONE ANALOG DESIGN - STRUCTURE-FUNCTION STUDIES TOWARD THE DEVELOPMENT OF AGONISTS AND ANTAGONISTS - RATIONALE AND PERSPECTIVE
    KARTEN, MJ
    RIVIER, JE
    [J]. ENDOCRINE REVIEWS, 1986, 7 (01) : 44 - 66
  • [8] PROLONGED DURATION OF GONADOTROPIN INHIBITION BY A 3RD GENERATION GNRH ANTAGONIST
    LEAL, JA
    WILLIAMS, RF
    DANFORTH, DR
    GORDON, K
    HODGEN, GD
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (06) : 1325 - 1327
  • [9] LEE CH, 1989, LIFE SCI, V45, P697
  • [10] SUPPRESSION OF PITUITARY-GONADAL FUNCTION BY A POTENT NEW LUTEINIZING-HORMONE-RELEASING HORMONE ANTAGONIST IN NORMAL MEN
    PAVLOU, SN
    WAKEFIELD, GB
    ISLAND, DP
    HOFFMAN, PG
    LEPAGE, ME
    CHAN, RL
    NERENBERG, CA
    KOVACS, WJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 64 (05) : 931 - 936